We are live on ! Find out more
NHI icon

National Health Investors

170 hedge funds and large institutions have $1.22B invested in National Health Investors in 2014 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 71 increasing their positions, 51 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 11

39% more repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 51

4% more funds holding

Funds holding: 163170 (+7)

5.63% less ownership

Funds ownership: 64.52%58.89% (-5.6%)

11% less capital invested

Capital invested by funds: $1.37B → $1.22B (-$151M)

Holders
170
Holders Change
+7
Holders Change %
+4.29%
% of All Funds
4.89%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
18
Increased
71
Reduced
51
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
U
51
UBS
Switzerland
$2.69M -$1.71M -27,747 -39%
Fifth Third Bancorp
52
Fifth Third Bancorp
Ohio
$2.67M +$7.89K +128 +0.3%
Legal & General Group
53
Legal & General Group
United Kingdom
$2.64M -$190K -3,086 -7%
VRS
54
Virginia Retirement Systems
Virginia
$2.5M +$1.33M +21,500 +117%
PPA
55
Parametric Portfolio Associates
Washington
$2.43M +$10.7K +174 +0.5%
ACI
56
AMP Capital Investors
Australia
$2.38M +$49.3K +800 +2%
UBS AM
57
UBS AM
Illinois
$2.33M +$228K +3,700 +11%
PC
58
Polar Capital
United Kingdom
$2.19M
Two Sigma Investments
59
Two Sigma Investments
New York
$2.1M -$1.43M -23,251 -41%
Swiss National Bank
60
Swiss National Bank
Switzerland
$2M +$160K +2,600 +9%
AQR Capital Management
61
AQR Capital Management
Connecticut
$1.97M +$419K +6,800 +28%
MLICM
62
Metropolitan Life Insurance Company (MetLife)
New York
$1.93M +$123K +2,002 +7%
Schroder Investment Management Group
63
Schroder Investment Management Group
United Kingdom
$1.9M +$1.36M +21,983 +263%
Barclays
64
Barclays
United Kingdom
$1.86M +$1.24M +20,044 +199%
BA
65
BlackRock Advisors
Delaware
$1.84M +$330K +5,352 +22%
HSBC Holdings
66
HSBC Holdings
United Kingdom
$1.83M -$470K -7,613 -21%
State Board of Administration of Florida Retirement System
67
State Board of Administration of Florida Retirement System
Florida
$1.81M +$43.5K +705 +3%
HighTower Advisors
68
HighTower Advisors
Illinois
$1.8M +$1.77M +28,733 New
NFA
69
Nationwide Fund Advisors
Ohio
$1.58M +$161K +2,607 +12%
Nisa Investment Advisors
70
Nisa Investment Advisors
Missouri
$1.56M +$308K +5,000 +25%
Commonwealth Equity Services
71
Commonwealth Equity Services
Massachusetts
$1.52M -$22.8K -370 -2%
BlackRock
72
BlackRock
New York
$1.51M +$74.9K +1,214 +5%
AAM
73
Aberdeen Asset Management
United Kingdom
$1.41M +$1.39M +22,500 New
CA
74
CapWealth Advisors
Tennessee
$1.41M +$245K +3,970 +21%
AIG
75
American International Group
New York
$1.38M -$215K -3,478 -14%

NHI Hedge Fund Activity: Q2 2014 in Review

170 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in National Health Investors (NHI) for Q2 2014, worth a combined $1.22B — down 11% from $1.37B a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new NHI positions and 11 closed out — a net gain of 7 holders — while 71 added to existing stakes and 51 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $25.2M. The largest seller was BNP Paribas Financial Markets, cutting an estimated $123M.

  • 170 institutional investors held National Health Investors (NHI) as of Q2 2014, up from 163 in Q1 2014.
  • Funds reported $1.22B of National Health Investors stock for Q2 2014, down 11% quarter-over-quarter.
  • 18 funds opened new National Health Investors positions in Q2 2014 and 11 closed out, a net change of +7 holders.
  • The largest National Health Investors buyer in Q2 2014 was Goldman Sachs, an estimated $25.2M added.
  • The largest National Health Investors seller in Q2 2014 was BNP Paribas Financial Markets, an estimated $123M sold.

Based on aggregated 13F filings for Q2 2014.